# VIBRANT: VIB4920 for Active Lupus Nephritis

> **NCT05201469** · PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 74 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** VIB4920
- **DRUG:** Placebo for VIB4920

## Key facts

- **NCT ID:** NCT05201469
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-16
- **Primary completion:** 2026-08
- **Final completion:** 2027-03
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05201469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05201469, "VIBRANT: VIB4920 for Active Lupus Nephritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05201469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*